Open AccessNovel reaction to new cystic fibrosis medication Trikafta
Author(s) -
Stashower Julian,
Carr Patrick,
Miller Virginia,
Zlotoff Barrett
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4116
Subject(s) - medicine , cystic fibrosis , ivacaftor , drug reaction , drug , intensive care medicine , pharmacology , cystic fibrosis transmembrane conductance regulator
We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta.